WebFeb 9, 2024 · As of February 8, 2024, the average one-year price target for Cytokinetics is $63.31. The forecasts range from a low of $47.47 to a high of $84.00. The average price target represents an increase... WebThe Investor Relations website contains information about Corteva Agriscience's business for stockholders, potential investors, and financial analysts. Investors Corteva Agriscience Skip to main navigation IR Home Company Corteva.com History Leadership Events & Presentations Financial Information Quarterly Earnings Reports
Fmr Updates Holdings in Cytokinetics (CYTK) Nasdaq
WebApr 10, 2024 · SOUTH SAN FRANCISCO, Apr 10, 2024 (GLOBE NEWSWIRE via COMTEX) -- SOUTH SAN FRANCISCO, Calif., April 10, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that ... WebCytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635 (c) (4) Yahoo. 04/03 16:00. UBS Adjusts Cytokinetics Price Target to $61 From $67, Maintains Buy Rating. MT Newswires. 04/03 10:50. Cantor Fitzgerald Adjusts Price Target on Cytokinetics to $59 From $61, Maintains Overweight Rating. MT Newswires. dcs projet
Cytokinetics To Participate In The 22nd Annual Needham
Web1 day ago · Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle … WebApr 10, 2024 · Cytokinetics To Participate In The 22nd Annual Needham Virtual Healthcare Conference. SOUTH SAN FRANCISCO, Calif., April 10, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK ... WebJan 7, 2024 · Cytokinetics Joanna Siegall Senior Manager, Corporate Communications, Investor Relations (425) 314-1721 Royalty Pharma Investor Relations and … dcs su 30 skins